Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter
Research Papers

Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress

Thiago Wendt Viola, Saulo Gantes Tractenberg, Mateus Luz Levandowski, Júlio Carlos Pezzi, Moisés Evandro Bauer, Antonio Lúcio Teixeira and Rodrigo Grassi-Oliveira
J Psychiatry Neurosci May 01, 2014 39 (3) 206-214; DOI: https://doi.org/10.1503/jpn.130027
Thiago Wendt Viola
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saulo Gantes Tractenberg
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mateus Luz Levandowski
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Júlio Carlos Pezzi
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moisés Evandro Bauer
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Lúcio Teixeira
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodrigo Grassi-Oliveira
Viola, Tractenberg, Levandowski, Bauer, Grassi-Oliveira — Centre of Studies and Research in Traumatic Stress, PostGraduate Program in Psychology, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Pezzi — Post-Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil; Bauer, Grassi-Oliveira — Laboratory of Immunosenescence, Institute of Biomedical Research, Pontifical Catholic University of the Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Teixeira — Neuroscience Program, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Fig. 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1

    General linear models, adjusted for age and body mass index, showing differences in neurotrophic factors plasma levels between women with crack cocaine dependence with (CSA+) and without (CSA−) a history of childhood sexual abuse and healthy controls. All data are presented raw (means and standard errors of the mean). Repeated-measures analyses of covariance (ANCOVAs) showed independent pairwise comparisons among the estimated marginal means. (A) Effect of group: CSA+ > CSA−, p = 0.001; effect of time: [18 d], [11 d] > [4 d], all p < 0.001. (B–D) No specific effect of group or time. (E) No specific effect of group; effect of time: day 18 and day 11 greater than day 4, all p < 0.005. These analyses revealed a significant group × time interaction effect for glial cell line–derived neurotrophic factor (GDNF; p = 0.001) and neurotrophic factor-4/5 (NT-4/5; p = 0.004) levels and a significant general effect of time for nerve growth factor (NGF; p = 0.026). The examination of group differences at separate time points using ANCOVAs with revealed significant differences among the 3 groups: (A) c greater than f (p < 0.001); d greater than g and a (all p < 0.05); (B) h–m greater than n (all p < 0.005); (C) o greater than p–u (all p < 0.005); (D) no pairwise comparison effects; and (E) f″ greater than i″ (p = 0.012). NT-3 = neurotrophic factor-3.

Tables

  • Figures
    • View popup
    Table 1

    Demographic, clinical and psychosocial characteristics of the groups

    Group; no. (%)*
    CharacteristicCSA+, n = 22CSA−, n = 82Control, n = 20Statisticp value
    Age, mean ± SD yr31.8 ± 6.228.1 ± 7.629.5 ± 8.8F2,120 = 2.120.12
    Menstrual cycleχ22 = 0.420.80
     Follicular phase13 (59.1)47 (57.3)10 (50)——
     Luteal phase9 (40.9)35 (42.6)10 (50)——
    Comorbidities
     Depressive episode6 (27.2)13 (15.8)—χ21 = 1.350.24
     Bipolar disorder1 (4.5)11 (13.4)—χ21 = 1.160.28
     Posttraumatic stress disorder5 (22.7)7 (8.5)—χ21 = 2.980.08
     Other axis I disorder4 (18.1)8 (9.7)—χ21 = 1.530.21
    Medication
     Mood stabilizers10 (45.5)44 (53.7)—χ21 = 0.460.49
     Neuroleptics10 (45.5)48 (58.5)—χ21 = 1.210.27
     Antidepressants1 (4.5)7 (8.5)—χ21 = 0.380.53
    CTQ–CSA, mean ± SD18.31 ± 5.256.08 ± 2.52—U = 98†< 0.001
    BMI, mean ± SD
     Baseline22.8 ± 3.122.3 ± 3.523.7 ± 3.2F2,121 = 1.400.24
     11 d23.7 ± 3.223.1 ± 3.7—F2,121 = 0.43‡0.65
     18 d24.3 ± 3.523.9 ± 3.4—F2,121 = 0.14‡0.86
    • BMI = Body Mass Index; CSA+ = crack cocaine dependence with a history of childhood sexual abuse; CSA− = crack cocaine dependence without a history of childhood sexual abuse; CTQ = Childhood Trauma Questionnaire; SD = standard deviation.

    • ↵* Unless otherwise indicated.

    • ↵† U = Wilcoxon Mann Whitney test.

    • ↵‡ Phase of menstrual cycle during first week of hospitalization.

    • View popup
    Table 2

    Clinical characteristics of groups

    Group; mean ± SD*
    CharacteristicCSA+, n = 22CSA−, n = 82Statistic*p value
    ASI-6
    Drugs60.7 ± 8.863.2 ± 10.1U = 7900.36
    Family/child67.5 ± 8.366.9 ± 8.9U = 8610.74
    Alcohol50.8 ± 9.750.4 ± 9.7U = 8710.80
    Psychiatric diagnosis59.0 ± 6.056.4 ± 5.3U = 6180.017
    Medical47.8 ± 7.747.0 ± 6.7U = 8070.45
    Legal58.7 ± 9.562.4 ± 8.1U = 6770.07
    Employment44.0 ± 6.944.0 ± 8.2U = 8990.98
    Family social support46.9 ± 12.445.6 ± 11.8U = 8340.58
    Family social problem56.4 ± 9.056.4 ± 9.2U = 8980.97
    Prior hospital admissions in last 6 mo owing to relapse, no. (%)10 (45.5)15 (19.5)†χ21 = 6.110.013
    Age at first crack cocaine use, yr19.2 ± 6.418.5 ± 5.2U = 6570.92
    Duration, yr, of crack use ≥ 3 times/wk5.5 ± 5.34.6 ± 3.4U = 7030.99
    Days of consumption in last mo15.6 ± 13.516.2 ± 13.2U = 6140.79
    Withdrawal prior to admission, d3.9 ± 7.32.3 ± 3.8U = 7500.85
    Alcohol use > 50 times, no. (%)11 (50)37 (45.1)χ21 = 0.390.53
    Powder cocaine use > 50 times, no. (%)10 (45.4)58 (70.7)χ21 = 3.440.06
    Marijuana use > 50 times, no. (%)22 (100)82 (100)——
    Beck Depression Inventory
     4 d33.5 ± 15.529.0 ± 14.6t102 = −1.280.20
     11 d24.2 ± 14.220.7 ± 13.5t102 = −1.070.28
     18 d18.7 ± 12.317.4 ± 11.3t102 = −1.280.63
    Cocaine Selective Severity Assessment
     4 d60.9 ± 17.655.6 ± 17.4t101 = −1.220.22
     11 d53.4 ± 30.047.6 ± 18.5t101 = −1.110.26
     18 d53.0 ± 20.345.3 ± 16.4t100 = −1.810.07
    • ASI-6 = Addiction Severity Index; CSA+ = crack cocaine dependence with a history of childhood sexual abuse; CSA− = crack cocaine dependence without a history of childhood sexual abuse; SD = standard deviation.

    • ↵* Wilcoxon Mann Whitney test unless otherwise indicated.

    • ↵† n = 77.

PreviousNext
Back to top

In this issue

Journal of Psychiatry and Neuroscience: 39 (3)
J Psychiatry Neurosci
Vol. 39, Issue 3
1 May 2014
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress
(Your Name) has sent you a message from JPN
(Your Name) thought you would like to see the JPN web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress
Thiago Wendt Viola, Saulo Gantes Tractenberg, Mateus Luz Levandowski, Júlio Carlos Pezzi, Moisés Evandro Bauer, Antonio Lúcio Teixeira, Rodrigo Grassi-Oliveira
J Psychiatry Neurosci May 2014, 39 (3) 206-214; DOI: 10.1503/jpn.130027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress
Thiago Wendt Viola, Saulo Gantes Tractenberg, Mateus Luz Levandowski, Júlio Carlos Pezzi, Moisés Evandro Bauer, Antonio Lúcio Teixeira, Rodrigo Grassi-Oliveira
J Psychiatry Neurosci May 2014, 39 (3) 206-214; DOI: 10.1503/jpn.130027
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire